Evidence map›Paper›PMID 40572717›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Illuminating Bilateral Breast Cancer: A Multicenter Experience and Clinical Observations.

Berkan Karabuğa, Mustafa Büyükkör, Ekin Konca Karabuğa, Sedat Yıldız, Mirmehdi Mehtiyev, Havva Yeşil Çınkır, Sıla Soylu Koçoğlu, Hacer Demir, Ozan Yazıcı, Doğan Uncu and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Berkan KarabuğaDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.ORCID 0000-0001-5357-7610
Mustafa BüyükkörDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.
Ekin Konca KarabuğaDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Sedat YıldızDepartment of Medical Oncology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey.
Mirmehdi MehtiyevDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
Havva Yeşil ÇınkırDepartment of Medical Oncology, Gaziantep University Faculty of Medicine, Gaziantep 27310, Turkey.
Sıla Soylu KoçoğluDepartment of Medical Oncology, Gazi University Faculty of Medicine, Ankara 06560, Turkey.
Hacer DemirDepartment of Medical Oncology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey.
Ozan YazıcıDepartment of Medical Oncology, Gazi University Faculty of Medicine, Ankara 06560, Turkey.
Doğan UncuDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.ORCID 0000-0002-0929-3271
Ömür Berna ÖksüzoğluDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Ülkü Yalçıntaş ArslanDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsNeoplasms, Multiple PrimaryAdultAgedDisease-Free SurvivalFemaleHumansMiddle AgedRetrospective StudiesRisk Factorsbilateral breast cancermetachronoussynchronous

Identifiers

PMID40572717
PMCPMC12195439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.